Allstate (NYSE:ALL) Insider Sells $4,706,857.91 in Stock

The Allstate Corporation (NYSE:ALL) insider Suren Gupta sold 21,871 shares of the company’s stock in a transaction on Friday, November 21st. The shares were sold at an average price of $215.21, for a total value of $4,706,857.91. Following the transaction, the insider directly owned 100,646 shares in the company, valued at $21,660,025.66. This trade represents a 17.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Suren Gupta also recently made the following trade(s):

• On Monday, November 24th, Suren Gupta sold 600 shares of Allstate stock. The stock was sold at an average price of $215.02, for a total transaction of $129,012.00.
• On Monday, November 17th, Suren Gupta sold 400 shares of Allstate stock. The shares were sold at an average price of $215.22, for a total transaction of $86,088.00.
• On Friday, November 14th, Suren Gupta sold 1,400 shares of Allstate stock. The shares were sold at an average price of $215.02, for a total value of $301,028.00.

Allstate Stock Performance

Shares of ALL stock opened at $213.92 on Thursday. The stock has a market cap of $55.98 billion, a PE ratio of 10.06, a price-to-earnings-growth ratio of 0.69 and a beta of 0.35. The stock has a 50-day moving average of $204.37 and a 200-day moving average of $202.28. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.43 and a quick ratio of 0.43. The Allstate Corporation has a one year low of $176.00 and a one year high of $215.89.

Allstate (NYSE:ALL) last issued its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $11.17 EPS for the quarter, topping the consensus estimate of $5.48 by $5.69. The business had revenue of $17.26 billion for the quarter, compared to the consensus estimate of $16.59 billion. Allstate had a return on equity of 28.74% and a net margin of 8.79%.The firm’s revenue was up 3.8% compared to the same quarter last year. During the same quarter last year, the business posted $3.91 EPS. As a group, sell-side analysts expect that The Allstate Corporation will post 18.74 earnings per share for the current year.

Allstate Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 1st will be given a dividend of $1.00 per share. The ex-dividend date of this dividend is Monday, December 1st. This represents a $4.00 dividend on an annualized basis and a yield of 1.9%. Allstate’s dividend payout ratio is 12.95%.

Institutional Trading of Allstate

Several institutional investors have recently added to or reduced their stakes in ALL. Norges Bank bought a new position in Allstate during the second quarter worth about $482,870,000. Price T Rowe Associates Inc. MD increased its holdings in shares of Allstate by 25.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 11,709,610 shares of the insurance provider’s stock worth $2,424,710,000 after purchasing an additional 2,374,684 shares during the period. Boston Partners raised its position in shares of Allstate by 613.9% in the first quarter. Boston Partners now owns 2,482,654 shares of the insurance provider’s stock valued at $512,627,000 after buying an additional 2,134,893 shares in the last quarter. Swedbank AB boosted its stake in shares of Allstate by 2,157.8% in the third quarter. Swedbank AB now owns 861,725 shares of the insurance provider’s stock valued at $184,969,000 after buying an additional 823,559 shares during the period. Finally, Woodline Partners LP acquired a new stake in Allstate during the third quarter worth approximately $148,641,000. 76.47% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on ALL. JPMorgan Chase & Co. increased their price objective on shares of Allstate from $254.00 to $260.00 and gave the stock an “overweight” rating in a research note on Thursday, November 6th. Morgan Stanley increased their price target on Allstate from $235.00 to $245.00 and gave the company an “overweight” rating in a research report on Friday, August 1st. Citigroup raised Allstate to a “hold” rating in a research report on Wednesday, August 13th. Keefe, Bruyette & Woods increased their price objective on Allstate from $246.00 to $250.00 and gave the company an “outperform” rating in a report on Tuesday, November 11th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Allstate in a research note on Wednesday, October 8th. Two investment analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $237.92.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.